Oct 1, 2026 | NEWS
An international genetic study led by scientists at Amgen deCODE genetics suggests that the hormone aldosterone is more important to the pathology of resistant hypertension than previously thought. One in six hypertensive Icelanders has a drug-resistant form of the...
Aug 19, 2026 | NEWS
Scientists at Amgen deCODE genetics have constructed the first Icelandic pangenome. A new method identifies 6% more genetic variants than previous methods and has already revealed a previously undetected variant associated with a substantially increased risk of...
Jul 30, 2026 | NEWS
In a landmark study published in Nature Medicine (https://www.nature.com/articles/s41591-026-04492-6), an international team of researchers have identified new genetic risk factors associated with fibromyalgia suggesting that the biological basis of the condition is...
May 15, 2026 | NEWS
deCODE genetics, a subsidiary of the global biotechnology company Amgen, today announced the appointment of Daníel F. Guðbjartsson, Ph.D. as Associate Vice President and Site Head. In this role, Dr. Guðbjartsson will lead site operations for deCODE genetics, further...
